Skip to content

Clinical study for the effect of Continuous Renal Replacement Therapy on filter life in different models

Clinical study for the effect of Continuous Renal Replacement Therapy on filter life in different models

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029873
Enrollment
Unknown
Registered
2020-02-16
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuous renal replacement therapy

Interventions

Research group:CVVHDF modal
control group:CVVHmodal

Sponsors

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Excessive capacity load: Patients who maintain hemodialysis or acute renal failure with congestive heart failure and acute pulmonary edema; When oliguria is needed and a lot of fluid is needed, such as TPN or various medications; Chronic edema, such as ascites, renal edema; 2. Clear solute: Acute renal failure with cardiovascular dysfunction; Acute renal failure with cerebral edema; Acute renal failure with high catabolism; Acute renal failure with comorbidities; Need for intravenous nutrition. 3. Acid-base and electrolyte disorders: Metabolic acidosis; Metabolic alkalosis; Hypernatremia or hyponatremia; Hyperkalemia or hypokalemia. 4. Non-kidney diseases: Acute necrotizing pancreatitis; Crush syndrome; Cardiopulmonary bypass; Drug or poisoning, hepatic encephalopathy; Cooling, rewarming.

Exclusion criteria

Exclusion criteria: 1. Age 75 years; 2. Patients with intracerebral hemorrhage and active bleeding who cannot use heparin anticoagulant; 3. Unable to establish appropriate vascular access, poor pipelines, and unstable blood flow.

Design outcomes

Primary

MeasureTime frame
Filter life;TMP;Filter pressure drop;CRRT related fees;CRRT running time (h);

Secondary

MeasureTime frame
BUN;BUN;blood Cr;long of stay ICU;Mechanical ventilation time;28-day mortality;Myoglobin;Total heparin dose (u);

Countries

China

Contacts

Public ContactXu Qiancheng

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)

xu871011@126.com+86 18297529106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026